These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2680372)

  • 1. Change in solubility of insulin in therapeutic mixtures of insulin preparations: HPLC analysis.
    Arakawa Y; Kurokawa N; Maeda Y; Yanaihara C
    Diabetes Res Clin Pract; 1989; 7 Suppl 1():S93-100. PubMed ID: 2680372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubility changes on mixing short- and long-acting insulin preparations.
    Havlik I; Galasko G; Alberts E; Furman KI; Seftel HC
    S Afr Med J; 1988 Mar; 73(6):361-2. PubMed ID: 3281288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on the absorption kinetics of subcutaneously administered insulin].
    Misawa K
    Hokkaido Igaku Zasshi; 1989 Nov; 64(6):792-812. PubMed ID: 2691384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of mixing human soluble and human crystalline zinc-suspension insulin: plasma insulin and blood glucose profiles after subcutaneous injection.
    Francis AJ; Hanning I; Alberti KG
    Diabet Med; 1985 May; 2(3):177-80. PubMed ID: 2952414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced solubility of short-acting soluble insulins when mixed with longer-acting insulins.
    Nolte MS; Poon V; Grodsky GM; Forsham PH; Karam JH
    Diabetes; 1983 Dec; 32(12):1177-81. PubMed ID: 6360762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mixing short- and intermediate-acting insulins on absorption course and biologic effect of short-acting preparation.
    Forlani G; Santacroce G; Ciavarella A; Capelli M; Mattioli L; Vannini P
    Diabetes Care; 1986; 9(6):587-90. PubMed ID: 3542453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption kinetics and action profiles of mixtures of short- and intermediate-acting insulins.
    Heine RJ; Bilo HJ; Fonk T; van der Veen EA; van der Meer J
    Diabetologia; 1984 Dec; 27(6):558-62. PubMed ID: 6397384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.
    Berger M; Cüppers HJ; Hegner H; Jörgens V; Berchtold P
    Diabetes Care; 1982; 5(2):77-91. PubMed ID: 6765510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of insulin mixtures in type I diabetics: influence of the intermediate acting insulin on the action of short acting insulin.
    Goicolea I; Quiroga A; Vazquez JA
    Diabete Metab; 1987; 13(4):467-70. PubMed ID: 3315768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixtures of human intermediate and human regular insulin in type 1 diabetic patients. Evaluation of free insulin levels and insulin action on glucose metabolism after combined and separate subcutaneous administration.
    Klauser R; Schernthaner G; Prager R
    Diabetes Res Clin Pract; 1988 Sep; 5(3):185-90. PubMed ID: 3065016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miscibility of human semisynthetic regular and lente insulin and human biosynthetic regular and NPH insulin.
    Olsson PO; Hans A; Henning VS
    Diabetes Care; 1987; 10(4):473-7. PubMed ID: 3304898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of mixing regular- and intermediate-acting insulins on their absorption and biological activity.
    Schulz B; Menzel R; Besch W
    Exp Clin Endocrinol; 1988 Mar; 91(1):27-34. PubMed ID: 3286272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of insulin mixtures in disposable plastic insulin syringes.
    Adams PS; Haines-Nutt RF; Town R
    J Pharm Pharmacol; 1987 Mar; 39(3):158-63. PubMed ID: 2883277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble and Lente human insulin mixtures in normal man.
    Owens DR; Vora JP; Jones IR; Birtwell J; Atiea J; Luzio S; Williams S
    Diabetes Res; 1988 Jan; 7(1):35-40. PubMed ID: 3042252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption kinetics of semisynthetic human insulin and biosynthetic (recombinant DNA) human insulin.
    Kemmer FW; Sonnenberg G; Cüppers HJ; Berger M
    Diabetes Care; 1982; 5 Suppl 2():23-8. PubMed ID: 6765535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology of human insulin.
    Heinemann L; Richter B
    Diabetes Care; 1993 Dec; 16 Suppl 3():90-100. PubMed ID: 8299482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous use of regular human insulin (Novo): pharmacokinetics and continuous insulin infusion therapy.
    Sonnenberg GE; Kemmer FW; Cüppers HJ; Berger M
    Diabetes Care; 1983; 6 Suppl 1():35-9. PubMed ID: 6343035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate-acting insulin preparations: NPH and lente.
    Deckert T
    Diabetes Care; 1980; 3(5):623-6. PubMed ID: 7192205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and miscibility of 4 highly purified porcine insulins: a study in vitro and in healthy volunteers.
    Heine RJ; Van der Stap H; Salemink PJ; Kolkman-Roodbeen JC; Banken P; Gribnau TC; van der Veen EA
    Diabetes Res; 1987 Jan; 4(1):45-50. PubMed ID: 3552367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin concentrations and time-action profiles of three different intermediate-acting insulin preparations in nondiabetic volunteers under glucose-controlled glucose infusion technique.
    Bottermann P; Gyaram H; Wahl K; Ermler R; Lebender A
    Diabetes Care; 1982; 5 Suppl 2():43-52. PubMed ID: 6765540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.